Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01740154 · ClinicalTrials.gov registry record · NA
Sunitinib Malate Related Fatigue in Patients With Metastatic Kidney Cancer
A NA study, sponsored by Case Comprehensive Cancer Center.
- Terminated
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT01740154 is a NA study that was terminated before completion, run by Case Comprehensive Cancer Center. The registered enrollment target is 13 participants.
The verdict
NCT01740154, a NA study, was terminated before completion, sponsored by Case Comprehensive Cancer Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
The purpose of this research study is to determine how sunitinib (sunitinib malate) causes fatigue. Patients will be asked to complete a brief questionnaire (survey) to rate their levels of fatigue every two weeks while they are participating in this research study. The questionnaire takes approximately 10-15 minutes to complete and is 9 questions. A series of physical measurements for fatigue will be performed before the first dose of sunitinib and again (4) weeks later to see if there are any changes in physical level of fatigues
Interventions
- OTHER survey administration
- PROCEDURE transcranial magnetic stimulation
- DRUG sunitinib malate
- PROCEDURE electromyography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2012-09 |
| Est. Completion | 2014-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01740154
The ClinicalTrials.gov registry entry for NCT01740154 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which survey administration is the first listed.
NCT01740154 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01740154 about?
NCT01740154 is a clinical study titled "Sunitinib Malate Related Fatigue in Patients With Metastatic Kidney Cancer". The purpose of this research study is to determine how sunitinib (sunitinib malate) causes fatigue. Patients will be asked to complete a brief questionnaire (survey) to rate their levels of fatigue every two weeks while they are participating in this research study. The questionnaire takes approxima...
What is the current status of trial NCT01740154?
This trial is currently terminated. It is a NA study. The enrollment target is 13 participants. The study started on 2012-09. Estimated completion is 2014-03.
What interventions are being tested in trial NCT01740154?
The interventions under investigation include: survey administration (OTHER), transcranial magnetic stimulation (PROCEDURE), sunitinib malate (DRUG), electromyography (PROCEDURE).
Who is sponsoring clinical trial NCT01740154?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.